These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17895509)

  • 1. Hemostasis activation in thrombophilic subjects with or without a history of venous thrombosis.
    Cuderman TV; Bozic M; Peternel P; Stegnar M
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):55-62. PubMed ID: 17895509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
    Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
    Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass.
    Raivio P; Petäjä J; Kuitunen A; Lassila R
    Ann Thorac Surg; 2008 Feb; 85(2):536-42. PubMed ID: 18222259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
    Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of hemostasis in patients with chronic cholecystitis].
    Kłoczko J; Lewandowski JJ; Galar M; Mazgajska-Barczyk K; Panek M
    Pol Merkur Lekarski; 2001 Jan; 10(55):19-20. PubMed ID: 11320544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease.
    Trotti R; Carratelli M; Barbieri M; Micieli G; Bosone D; Rondanelli M; Bo P
    Haematologica; 2001 Jan; 86(1):85-91. PubMed ID: 11146576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1 + 2.
    Lambropoulos AF; Foka Z; Makris M; Daly M; Kotsis A; Makris PE
    Blood Coagul Fibrinolysis; 1997 Nov; 8(8):485-9. PubMed ID: 9491265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
    Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
    Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
    Legnani C; Preda L; Palareti G; Lunghi B; Rossi E; Coccheri S
    Haematologica; 2002 Feb; 87(2):182-8. PubMed ID: 11836169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis.
    Anžej Doma S; Vučnik M; Božič Mijovski M; Peternel P; Stegnar M
    Thromb Res; 2013 Nov; 132(5):621-6. PubMed ID: 24083963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The thrombophilic status of patients with inflammatory diseases].
    Lins M; Zurborn KH; Pries B; Bruhn HD
    Dtsch Med Wochenschr; 1996 Jul; 121(27):855-9. PubMed ID: 8681740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members.
    Demarmels Biasiutti F; Sulzer I; Stucki B; Wuillemin WA; Furlan M; Lämmle B
    Thromb Haemost; 1998 Jul; 80(1):167-70. PubMed ID: 9684804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
    Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
    Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
    Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
    Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
    van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
    Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
    Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
    Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
    Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.